Patents for A61P 33 - Antiparasitic agents (21,787)
10/2006
10/17/2006US7122528 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
10/17/2006US7122525 Targeted therapeutics and uses thereof
10/17/2006US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/12/2006US20060230467 Plant deoxyribonucleoside kinase enzymes and their use
10/12/2006US20060229263 each case in free form or in salt form; pesticidal compositions in which the active ingredient has been selected from those compounds and their tautomers; and a method of controlling pests using those compositions are described.** Image-1
10/12/2006US20060229236 Cyclic tetrapeptide compound and use thereof
10/12/2006US20060228382 Lipoglycan compositions and methods of treating parasitic infections
10/12/2006US20060228303 Method of screening for genes that influence pathological conditions or survival of animals infected with pathogen
10/11/2006EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/11/2006EP1710242A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha levels
10/11/2006EP1710236A1 Derivatives of pyridine and quinoline
10/11/2006EP1708673A2 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies
10/11/2006CN1843510A Preparation method and medicinal uses of Trichinella eelworm vaccine
10/11/2006CN1843364A Pharmaceutical for preventing and treating coccidiosis, and its usage method
10/11/2006CN1279054C Type I cytokine receptor TCCR
10/11/2006CN1278735C Crystallographic form of a cyclic depsipeptide having improved activity
10/10/2006US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens
10/10/2006US7119095 Pharmaceutically active compounds and methods of use thereof
10/08/2006CA2540736A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
10/08/2006CA2503932A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
10/05/2006US20060223803 Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome
10/05/2006US20060222723 Terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
10/04/2006EP1707206A1 Piperazine derivates for the inhibition of beta-secretase, cathepsin D, plasmepsin ll and HIV protease and for the treatment of malaria, Alzeheimer and AIDS
10/04/2006EP1707202A1 Organic compounds
10/04/2006EP1706114A1 Chemical inhibitors of soluble adenylyl cyclase (sac)
10/04/2006EP1706110A1 Therapeutic use of quinonoid derivatives of cannabinoids
10/04/2006EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide
10/04/2006EP1467622A4 Mitocidal compositions and methods
10/04/2006CN1840202A DNA vaccine for preventing haemonchus contortus disease of ruminant
10/04/2006CN1840156A Effervescence tablet for treating female genital disease and preparation method thereof
10/04/2006CN1839980A Medicine for treating gynecopathy and cypridopathy and its preparing method
10/04/2006CN1839879A Coccidian resistant solution containing diclazuril ,maduramicin ammonium and its preparation method
10/04/2006CN1839864A Compound avermectin injection
10/04/2006CN1839845A Coccidian resistant solution containing toltrazuril and its preparation method
10/04/2006CN1277830C Para-herqueinamide as medicine for resisting parasite
10/03/2006US7115280 Particle formation methods and their products
10/03/2006CA2231633C Process for the preparation of anti-malarial drugs
09/2006
09/28/2006US20060217551 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases
09/28/2006US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor
09/27/2006EP1703914A1 Apicomplex vaccine strains of a family of sarcocystidae
09/27/2006EP1268759B1 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
09/27/2006CN1837194A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
09/27/2006CN1276975C Recombinant protein containing C-terminal fragment of plasmodium MSP-1
09/26/2006US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
09/26/2006CA2102624C Transmission-blocking vaccine against malaria
09/21/2006WO2006097472A2 Novel inhibitors of glutathione-s-transferase
09/21/2006WO2006096905A1 Control of sucking lice
09/21/2006US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease
09/21/2006CA2600253A1 Control of sucking lice
09/20/2006EP1702983A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
09/20/2006EP1702616A1 Compound artemisinin
09/20/2006EP1701727A1 Dutpase inhibitors
09/20/2006CN1833691A Externally used Chinese patent medicine for treating colpomycosisor tricho monal vaginitis, and prepn. method
09/20/2006CN1275648C Vaccin composition, preparation method and use thereof
09/20/2006CN1275589C Slow releasing injection contg. antiparasitic medicine
09/19/2006US7109331 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives
09/19/2006US7109240 Non-hazardous pest control
09/19/2006US7109183 Phosphohalohydrins, process for the production thereof and use thereof
09/19/2006US7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
09/19/2006CA2292558C 1-amino-alkylcyclohexane nmda receptor antagonists
09/14/2006WO2006095195A1 Antimicrobial compounds
09/14/2006WO2006094799A2 Pyridinone derivatives against malaria
09/14/2006WO2006094664A1 Endoparasiticide
09/14/2006US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors
09/14/2006US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity
09/14/2006US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy
09/14/2006DE102005011779A1 Endoparasitizide Mittel Endoparasiticides means
09/14/2006CA2600638A1 Composition comprising emodepside and praziquantel or epsiprantel
09/13/2006EP1699799A1 Control of parasites in animals by the use of imidazo [1,2-b]pyridazine derivatives
09/13/2006EP1511752B1 Camptothecins with a modified lactone ring
09/13/2006EP1414813B1 1,2,4-trioxolane antimalarials
09/13/2006EP1244621B1 Nitrile derivatives as cathepsin k inhibitors
09/13/2006EP1196579B1 Tryptase inhibitor
09/13/2006CN1274689C Plant extract and its application
09/13/2006CN1274672C Aminoacetonitrile derivatives and their use for controlling parasites
09/12/2006US7105524 2-(3,4,4-Trifluoro-but-3-enylsulfanyl)-thiazolo[5,4-b]pyridine; treating, controlling warm-blooded animals, fish and humans against infestation and infection by nematodes, helminths, arachnids and arthropod endo- and ectoparasites.
09/12/2006US7105508 Integrin receptors antagonists
09/12/2006US7105179 Crystal forms of azithromycin
09/07/2006US20060199859 Topical medicaments and methods for photodynamic treatment of disease
09/07/2006US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid
09/07/2006US20060198850 Pharmaceutical formulation and a method of making same
09/07/2006US20060198841 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
09/07/2006DE102005009909A1 Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine Compounds suitable for the removal of misfolded proteins
09/06/2006EP1698701A1 Use of MHC class II ligands as adjuvant for vaccination and lag-3 in cancer treatment
09/06/2006EP1698629A2 Polyamines and their use in therapy
09/06/2006EP1696894A1 Treating infectious diseases using ice inhibitors
09/06/2006EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors
09/06/2006CN1827166A Animal medicine for resisting and treating poultry coccidiosis
09/06/2006CN1827127A Extraction method and technique of olive leaf extract
09/06/2006CN1827102A Bilogical adhesive tablet of ornidazole and method for preparing the same
09/06/2006CN1273120C Parasiticidal composition and methods of use
09/06/2006CN1273019C Parasiticide and parasitic method for globefish
09/05/2006US7101908 Nontoxic treatment for infections from cytomegalovirus
09/05/2006US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
09/05/2006US7101842 Such as transferrin-doxorubicin conjugate linked by gluteraldehyde; inexpensive, effective
09/05/2006US7101711 Activating a T gamma 9 delta 2 lymphocyte at a minimum activation concentration of below 100 nM, in vitro by contacting with a 3,4-epoxy-3-methyl-1-butyl diphosphate substituted with a biomolecule
09/05/2006US7101553 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients
09/05/2006US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response
08/2006
08/31/2006WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone
08/31/2006US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 218